Cervical Screening in General Practice: self-collection eligibility policy change and the intermediate risk pathway
On-demand recorded 12 Jul 2022
From 1 July 2022, the National Cervical Screening Program (NCSP) will expand Cervical Screening Test sample collection options, offering clinician collection or self-collection as a choice to all people participating in cervical screening. Expanding the option of self-collection to all participants is expected to increase participation in cervical screening, encouraging those who are under-screened to screen.
The Cancer Institute NSW and Royal College of General Practitioners are partnering in a one-hour webinar (date) to educate General Practitioners about the change to the self-collection policy and the critical role that General Practitioners play in supporting this change. The webinar will additionally include education on the clinical management of women at intermediate risk in the NCSP.
Learning outcomes
- Discuss what changes were made to the intermediate risk clinical pathway in February 2021 including changes to referral recommendations
- Be aware that self-collection eligibility policy changed on 1 July 2022 and discuss self collection exclusions according to National clinical guidelines
- Utilise appropriate referral pathways including when participants should be referred on to specialists
Facilitator
Dr Linda Mann
MBBS, FRACGP, DipRANZCOG, BScMED
Presenter
Dr Clare Boerma
Associate Medical Director at Family Planning NSW and GP
Dr Clare Boerma is the Associate Medical Director at Family Planning NSW as well as a General Practitioner. Clare was previously a conjoint associate lecturer at the school of Women’s and Children’s Health at UNSW. Clare has become increasingly engaged in reproductive and sexual health over the years, spreading her time across medical education, research and as a clinician at Family Planning NSW.